Tilray Inc. ($TLRY) Stock Forecast: Up 5.3% Today

What is Tilray Inc.?

Tilray Brands Inc (TLRY) operates in the cannabis industry with a diversified business model covering cannabis, beverage alcohol, and wellness products. Various factors such as regulatory changes, competition, and investor sentiment influence market volatility.

Why is Tilray Inc. going up?

TLRY stock is up 5.3% on May 20, 2026 15:26

• TLRY demonstrated a strong bullish movement despite recent stock pressures.
• Investor optimism in the industry might have been sparked by discussions on cannabis rescheduling and potential regulatory shifts.
• The introduction of new nostalgia-led cocktails by BrewDog, a subsidiary of Tilray, likely positively impacted market sentiment and consumer engagement.
• Positive news and potential catalysts like cannabis legalization and the SAFE banking act may have outweighed analysts' predictions of further declines.

TLRY Price Chart

TLRY Technical Analysis

TLRY News

Cannabis Stocks Draw Attention As Rescheduling Debate Gains Momentum

The debate surrounding cannabis rescheduling is bringing renewed attention to major marijuana companies. The industry is evolving through regulatory changes, business expansion, product diversification, and increased consumer engagement across North America. Companies like Tilray Brands, Canopy Growth, Curaleaf, and Cronos Group are closely watched during these discussions due to the potential for improved operational flexibility and financial accessibility.

https://kalkinemedia.com/us/stocks/cannabis/cannabis-stocks-draw-attention-as-rescheduling-debate-gains-momentum

Tilray Brands Inc stock (US88832Q1067): cannabis player under pressure after sharp price swings

Tilray Brands Inc (TLRY) shares are experiencing renewed pressure following a period of significant price volatility on North American exchanges. Despite its diversified business model encompassing cannabis, beverage alcohol, and wellness products, the company remains subject to regulatory shifts, competition, and investor sentiment. The article emphasizes that careful attention to company disclosures and sector developments is crucial for investors due to the stock's pronounced volatility.

https://www.ad-hoc-news.de/boerse/news/ueberblick/tilray-brands-inc-stock-us88832q1067-cannabis-player-under-pressure/69354134

Tilray Brands, Inc. Trade Ideas — XETR:2HQ0

This article compiles various trading ideas and analyses for Tilray Brands, Inc. (XETR:2HQ0, NASDAQ:TLRY) from different traders on TradingView. The perspectives range from predictions of further declines and short opportunities to expectations of breakouts, retests of support levels, and long-term holds based on technical indicators like falling wedges, inverse head and shoulders, and bullish divergences. Many analyses also cite potential catalysts like cannabis legalization and the SAFE banking act.

https://www.tradingview.com/symbols/XETR-2HQ0/ideas/page-15/

-4.55% for Tilray stock as disappointing earnings hit sentiment

Tilray (TLRY) shares recently dropped 4.55% to $5.25 following a disappointing earnings report that showed a quarterly loss of $0.24 per share and revenue below market expectations. Despite the acquisition of Lyphe Group to expand its medical cannabis presence in the UK, technical indicators suggest persistent selling pressure and a weak trend, with analysts predicting further downside or sideways movement. The stock trades significantly below its key moving averages, and a sustained rebound above $5.45 appears unlikely in the near term.

https://tradersunion.com/news/financial-news/show/2062777-tilray-slides-4-55percent-today-to/

BrewDog Shakes Up RTD Shelves Across the UK with New Nostalgia-Led Wonderland Cocktails | Tilray

BrewDog, by Tilray Brands, is launching new Wonderland cocktails inspired by nostalgic flavors into the UK ready-to-drink market. Initially available in Sainsbury's and online, the range includes Pear Drop Margarita and Fizzy Toffee Apple Martini, with additional flavors planned for future release. The brand aims to disrupt the category with unique, throwback-inspired offerings at 10% ABV, tapping into consumer demand for nostalgic tastes.

https://www.tilray.com/news/brewdog-shakes-up-rtd-shelves-across-the-uk-with-new-nostalgia-led-wonderland-cocktails/

Trending Today

Sunrun Inc. ($RUN) Stock Forecast: Up 5.2% Today

Opendoor Technologies Inc. ($OPEN) Stock Forecast: Up 5.5% Today

Leggett & Platt Incorporated ($LEG) Stock Forecast: Up 4.0% Today

CF Industries Holdings Inc. ($CF) Stock Forecast: Down 5.4% Today

Tandem Diabetes Care, Inc. ($TNDM) Stock Forecast: Up 5.1% Today

Tilray Inc. ($TLRY) Stock Forecast: Up 5.3% Today

Jetblue Airways Corporation ($JBLU) Stock Forecast: Up 5.4% Today

C3.ai Inc. ($AI) Stock Forecast: Up 5.2% Today

General Electric Company ($GE) Stock Forecast: Up 5.4% Today

Brent Crude Oil ($BRENT) Commodity Forecast: Down 5.4% Today

Tilray Inc. Price History

27.03.2026 - TLRY Stock was down 5.3%

• Investors opted to take profits today amidst Tilray's stock decline, following a period of volatility and speculation.
• Concerns arose among investors due to a director's sale of over 33,000 company shares, potentially impacting outlook and causing fears of dilution.
• Although positive developments such as U.S. cannabis rescheduling and the company's expansion plans emerged, the stock's decline suggests some skepticism among investors regarding the recent surge.
• Tilray's larger-than-expected quarterly loss and negative net margins may have also influenced the stock's downturn, prompting an evaluation of the company's financial standing in light of sector trends.

29.03.2026 - TLRY Stock was down 6.3%

• The stock price of Tilray dropped by 4.8% to $6.56, nearing its 52-week low and trading below its 200-day moving average, signaling bearish sentiment among investors.
• Despite the launch of new products by its subsidiary Manitoba Harvest, Tilray's stock faced continued selling pressure and technical indicators suggest a downside risk, potentially due to the company missing EPS estimates in the last quarter and reporting negative net margins.
• The underperformance of Tilray's stock compared to the broader market indices like the NASDAQ Composite and Dow Jones Industrial Average indicates specific challenges faced by the company, potentially related to its financial performance and market positioning.
• The overall US cannabis market is projected to grow significantly in the coming years, providing a positive industry outlook, but Tilray's specific stock movement today may be influenced by internal factors such as financial results and market sentiment rather than broader industry trends.

22.03.2026 - TLRY Stock was up 14.6%

• The surge in Tilray Brands Inc. (TLRY) can be linked to the filing of additional legal exhibits related to a registration statement. This move likely boosted investor confidence in the company's adherence to regulations and transparency.
• Despite the notification of an insider selling 232,872 shares, the market appeared more interested in the registration of 398,666 resalable common shares, issued for acquiring the Lyphe Group. This development hinted at potential growth avenues for the company.
• The stock's positive trajectory might also reflect a recovery from the previous day's downturn, where it performed below the market average. Investors seem to perceive this as a favorable moment to purchase following the recent price dip.
• In summary, the optimistic market sentiment surrounding Tilray Brands Inc. could stem from its regulatory compliance, growth potential from acquisitions, and a rebound from the previous day's underperformance.

08.04.2026 - TLRY Stock was down 5.1%

• TLRY's stock decline aligns with the negative trading day across the market, with the NASDAQ Composite Index and the Dow Jones Industrial Average also experiencing losses.
• The launch of Widmer Brothers' "Stay Sunny" campaign and their new beer releases may have steered investor focus and funds away from Tilray, impacting its stock performance.
• CEO Irwin Simon's positive outlook on expanding medical cannabis operations in the U.S. may not have fully offset concerns about Tilray's revenue inconsistency and ongoing losses.
• Investor uncertainties regarding the sluggish federal cannabis legalization progress and heightened competition from established beverage companies could have added to the bearish sentiment surrounding Tilray Brands Inc.

28.03.2026 - TLRY Stock was down 5.3%

• The exclusive launch of Manitoba Harvest's Superfood Smoothie Boosters at Sprouts Farmers Market suggests potential competition in the health and wellness sector, impacting investor sentiment towards Tilray.
• Concerns about growing competition and market saturation in the US cannabis market may have prompted a sell-off of TLRY shares.
• Anticipation surrounding Tilray's upcoming Q3 earnings report, which showed a wider loss than expected but beat revenue estimates, created uncertainty among investors despite the company's market outperformance.
• The market's mixed reactions to Tilray's Q3 earnings, with the stock price dropping despite surpassing revenue expectations, may have led investors to reassess the company's financial standing and future outlook.

23.03.2026 - TLRY Stock was up 8.6%

• Tilray's stock price rose by more than 30% due to discussions about the possible reclassification of cannabis, which could support the company's plans for growth in the US market.
• There is excitement among investors regarding the potential regulatory changes that could lead to tax benefits and smoother operations for cannabis firms.
• Tilray's preparedness to tap into the US medical cannabis sector after a potential reclassification showcases strategic opportunities for growth and market expansion.
• By collaborating with BrewDog USA, Tilray is demonstrating a diverse approach to innovation and product offerings, which is contributing to its optimistic market sentiment and upward trajectory.

24.03.2026 - TLRY Stock was down 12.9%

• The stock price of Tilray Brands plummeted by 11.8% following insider selling of over 33,000 shares by a director, leading to increased trading volume and negative investor sentiment.
• Despite optimism in the cannabis sector due to potential reclassification of cannabis to Schedule III, concerns about potential dilution, wider-than-expected quarterly losses, and negative net margins contributed to the bearish movement.
• While there was speculation and anticipation surrounding the Trump administration's possible rescheduling of cannabis, the lack of official confirmation led to uncertainty and a sell-off in Tilray's stock.
• Tilray's readiness to expand into the U.S. medical cannabis market post-rescheduling highlights the company's strategic positioning, but until concrete regulatory changes are announced, the stock may continue to face volatility and downward pressure.

21.03.2026 - TLRY Stock was down 5.2%

• TLRY experienced a strong bearish movement today despite recent positive news and stock price gains in the past few days.
• The stock's poor performance could be attributed to the challenges faced in the legal marijuana market, including restrictive regulations on branding and advertising, intense competition, and uncertainty surrounding potential U.S. legalization.
• Despite reaffirming its leadership in medical cannabis and positive company news, the stock's reaction indicates a stock-specific response rather than a broader sector trend.
• The bearish movement today may be a result of profit-taking by investors following the recent price increases, as well as concerns about the company's ability to overcome regulatory hurdles and achieve sustained profitability in a competitive market.

04.04.2026 - TLRY Stock was down 5.0%

• The stock's downward trend today could be linked to Tilray's larger-than-expected EPS loss, causing investor concerns over its financial standing.
• Despite positive remarks from the CEO regarding potential benefits from US cannabis reclassification, the market reaction may stem from Tilray's current lack of cannabis sales in the US, focusing on other product lines instead.
• Analyst sentiment on Tilray remains mixed, with an average "Hold" rating and insider share selling, possibly contributing to the stock's bearish sentiment.
• Market dynamics, including the NASDAQ Composite Index uptrend and the Dow Jones Industrial Average decline, may have further driven the negative pressure on Tilray's stock.

04.04.2026 - TLRY Stock was down 5.1%

• The company faced potential investor concerns with the launch of two new ready-to-drink cocktails by brand 10 Barrel Brewing, a Tilray subsidiary, raising worries about moving away from their core cannabis business.
• Despite surpassing revenue expectations, the stock's decline might be linked to Tilray's larger-than-expected EPS loss, creating uncertainties around the company's profitability and future growth.
• CEO Irwin Simon's positive remarks on the potential reclassification of US cannabis were overshadowed by negative factors like insider selling, stock trading below key moving averages, and overall market sentiment towards the stock.

05.04.2026 - TLRY Stock was down 6.4%

• Tilray's stock price dropped by 4.2% to $5.90, trading below key moving averages, following a wider-than-expected EPS loss of -$0.24 despite beating revenue estimates.
• The broader market also experienced losses, with the NASDAQ Composite Index dropping 0.19% and the Dow Jones Industrial Average falling 1.13%, contributing to Tilray's decline.
• The launch of two new ready-to-drink cocktails by 10 Barrel Brewing, a brand under Tilray, did not seem to positively impact the stock price, as investors may be more focused on the company's financial performance and profitability.
• Analysts' consensus "Hold" rating and lowered price targets suggest caution among investors, reflecting concerns about Tilray's current financial outlook and market conditions.

20.04.2026 - TLRY Stock was up 5.3%

• TLRY demonstrated a strong bullish movement despite recent stock pressures.
• Investor optimism in the industry might have been sparked by discussions on cannabis rescheduling and potential regulatory shifts.
• The introduction of new nostalgia-led cocktails by BrewDog, a subsidiary of Tilray, likely positively impacted market sentiment and consumer engagement.
• Positive news and potential catalysts like cannabis legalization and the SAFE banking act may have outweighed analysts' predictions of further declines.